SlideShare a Scribd company logo
Peptic Ulcer Disease
Peptic Ulcer Disease
 Condition characterized by
 Erosion of GI mucosa resulting from
digestive action of HCl and pepsin
Peptic Ulcer Disease
 Ulcer development
 Lower esophagus
 Stomach
 Duodenum
 10% of men, 4% of women
Types
 Acute
 Superficial erosion
 Minimal erosion
 Chronic
 Muscular wall erosion with formation
of fibrous tissue
 Present continuously for many months
or intermittently
Peptic Ulcer Disease
Etiology and Pathophysiology
 Develop only in presence of acid
environment
 Excess of gastric acid not necessary for
ulcer development
 Person with a gastric ulcer has normal to
less than normal gastric acidity
compared with person with a duodenal
ulcer
Peptic Ulcer Disease
Etiology and Pathophysiology
 Some intraluminal acid does seem to be
essential for a gastric ulcer to occur
 Pepsinogen is activated to pepsin in
presence of HCl and a pH of 2 to 3
 Secretion of HCl by parietal cells has a
pH of 0.8
 pH reaches 2 to 3 after mixing with
stomach contents
Peptic Ulcer Disease
Etiology and Pathophysiology
 At pH level 3.5 or more, stomach acid is
neutralized
 Pepsin has little or no proteolytic
activity
 Surface mucosa of stomach is renewed
about every 3 days
 Mucosa can continually repair itself
except in extreme instances
Peptic Ulcer Disease
Etiology and Pathophysiology
 Mucosal barrier prevents back diffusion
of acid from gastric lumen through
mucosal layers to underlying tissue
 Mucosal barrier can be impaired and
back diffusion can occur
Back-Diffusion of Acids
Fig. 40-13
Peptic Ulcer Disease
Etiology and Pathophysiology
 HCl freely enters mucosa when barrier is
broken
 Injury to tissue occurs
 Result: cellular destruction and
inflammation
Peptic Ulcer Disease
Etiology and Pathophysiology
 Histamine is released
 Vasodilation, ↑ capillary permeability
 Further secretion of acid and pepsin
Peptic Ulcer Disease
Etiology and Pathophysiology
 Ulcerogenic drugs inhibit synthesis of
prostaglandins and cause abnormal
permeability
 Corticosteroids ↓ rate of mucosal cell
renewal thereby ↓ protective effects
Peptic Ulcer Disease
Etiology and Pathophysiology
 When mucosal barrier is disrupted, there
is a compensatory ↑ in blood flow
 Prostaglandin-like substances,
histamines act as vasodilators
 Hydrogen ions are rapidly removed
 Buffers are delivered
 Nutrients arrive
 ↑ Mucosal cell replication
Disruption of Gastric Mucosal Barrier
Fig. 40-14
Peptic Ulcer Disease
Etiology and Pathophysiology
 When blood flow is not sufficient, tissue
injury results
Peptic Ulcer Disease
Etiology and Pathophysiology
 Two mechanisms that protect
 Mucus forms a layer that entraps or
slows diffusion of hydrogen ions across
mucosal barrier
 Bicarbonate is secreted
 Neutralizes HCl acid in lumen of GI tract
Peptic Ulcer Disease
Etiology and Pathophysiology
 ↑ Vagal nerve stimulation results in
hypersecretion of HCl acid
 ↑ HCl acid can alter mucosal barrier
 Duodenal ulcers are associated with ↑
acid
Gastric Ulcers
 Commonly found on lesser curvature in
close proximity to antral junction
 Less common than duodenal ulcers
 Prevalent in women, older adults,
persons from lower socioeconomic
class
Gastric Ulcers
 Characterized by
 A normal to low secretion of gastric
acid
 Back diffusion of acid is greater
(chronic)
Gastric Ulcers
 Critical pathologic process is amount of
acid able to penetrate mucosal barrier
 H. pylori is present in 50% to 70%
Gastric Ulcers
 H. pylori is thought to be more
destructive when noxious agents are used,
or patient smokes
Gastric Ulcers
 Drugs can cause acute gastric ulcers
 Aspirin, corticosteroids, NSAIDs,
reserpine
 Or known causative factors
 Chronic alcohol abuse, chronic gastritis
Duodenal Ulcers
 Occur at any age and in anyone
 ↑ Between ages of 35 to 45 years
 Account for ~80% of all peptic ulcers
Duodenal Ulcers
 Associated with ↑ HCl acid secretion
 H. pylori is found in 90-95% of patients
 Direct relationship has not been found
Duodenal Ulcers
 Diseases with ↑ risk of duodenal ulcers
 COPD, cirrhosis of liver, chronic
pancreatitis, hyperparathyroidism,
chronic renal failure
 Treatments used for these conditions may
promote ulcer development
Psychological Stress Ulcers
 Acute ulcers that develop following a
major physiologic insult such as trauma
or surgery
 A form of erosive gastritis
Psychological Stress Ulcers
 Gastric mucosa of body of stomach
undergoes a period of transient ischemia
in association with
 Hypotension
 Severe injury
 Extensive burns
 Complicated surgery
Psychological Stress Ulcers
 Ischemia due to ↓ capillary blood flow or
shunting of blood away from GI tract so
that blood flow bypasses gastric mucosa
 Imbalance between destructive
properties of HCl acid and pepsin, and
protective factors of stomach’s mucosal
barrier
Peptic Ulcer Disease
Clinical Manifestations
 Common to have no pain or other
symptoms
 Gastric and duodenal mucosa not rich
in sensory pain fibers
 Duodenal ulcer pain
 Burning, cramplike
 Gastric ulcer pain
 Burning, gaseous
Peptic Ulcer Disease
Complications
 3 major complications
 Hemorrhage
 Perforation
 Gastric outlet obstruction
 Initially treated conservatively
 May require surgery at any time during
course of therapy
Peptic Ulcer Disease
Hemorrhage
 Most common complication of peptic
ulcer disease
 Develops from erosion of
 Granulation tissue found at base of
ulcer during healing
 Ulcer through a major blood vessel
Peptic Ulcer Disease
Perforation
 Most lethal complication of peptic ulcer
 Commonly seen in large penetrating
duodenal ulcers that have not healed and
are located on posterior mucosal wall
Peptic Ulcer Disease
Perforation
 Perforated gastric ulcers often located on
lesser curvature of stomach
Peptic Ulcer Disease
Perforation
Fig. 40-15
Peptic Ulcer Disease
Perforation
 Occurs when ulcer penetrates serosal
surface
 Spillage of their gastric or duodenal
contents into peritoneal cavity
 Size of perforation directly proportional
to length of time patient has had ulcer
 Sudden, dramatic onset
Peptic Ulcer Disease
Gastric Outlet Obstruction
 Ulcers located in antrum and prepyloric
and pyloric areas of stomach
 Duodenum can predispose to gastric
outlet obstruction
 ↑ contractile force needed to empty
stomach results in hypertrophy of
stomach wall
Peptic Ulcer Disease
Gastric Outlet Obstruction
 After longstanding obstruction stomach
enters decompensated phase
 Results in dilation and atony
Peptic Ulcer Disease
Gastric Outlet Obstruction
 Obstruction is not totally due to fibrous
scar tissue
 Active ulcer formation is associated
with edema, inflammation,
pylorospasm
 All contribute to narrowing of pylorus
Peptic Ulcer Disease
Gastric Outlet Obstruction
 Usually has a history of ulcer pain
 Short duration or absence of pain
indicative of a malignant obstruction
Peptic Ulcer Disease
Gastric Outlet Obstruction
 Vomiting is common
 Constipation is a common complaint
 Dehydration, lack of roughage in diet
 May show swelling in upper abdomen
Peptic Ulcer Disease
Diagnostic Studies
 Endoscopy procedure most often used
 Determines degree of ulcer healing
after treatment
 Tissue specimens can be obtained to
identify H. pylori and to rule out
gastric cancer
Peptic Ulcer Disease
Diagnostic Studies
 Tests for H. pylori
 Noninvasive tests
 Serum or whole blood antibody tests
 Immunoglobin G (IgG)
 Urea breath test
 Invasive tests
 Biopsy of stomach
 Rapid urease test
Peptic Ulcer Disease
Diagnostic Studies
 Barium contrast studies
 Widely used
 X-ray studies
 Ineffective in differentiating a peptic
ulcer from a malignant tumor
Peptic Ulcer Disease
Diagnostic Studies
 Gastric analysis
 Identifying a possible gastrinoma
 Determining degree of gastric
hyperacidity
 Evaluating results of therapy
Peptic Ulcer Disease
Diagnostic Studies
 Laboratory analysis
 CBC
 Urinalysis
 Liver enzyme studies
 Serum amylase determination
 Stool examination

More Related Content

Similar to 4584623.ppt

Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
Ankit Pandey
 
.pptx
.pptx.pptx
Acute abdomen
Acute abdomenAcute abdomen
Acute abdomen
Uvaish Parmar
 
Git
GitGit
Acute abdomen
Acute abdomenAcute abdomen
Acute abdomen
Andey Rahman
 
gastic and duodenal disorders
gastic and duodenal disordersgastic and duodenal disorders
gastic and duodenal disorders
shabeel pn
 
Jejunal hemorrhagic syndrome
Jejunal hemorrhagic syndromeJejunal hemorrhagic syndrome
Jejunal hemorrhagic syndrome
MutahirRehman
 
PUD.pptx
PUD.pptxPUD.pptx
PUD.pptx
Dr.Sajid Hasan
 
Peptic ulcer.pdf
Peptic ulcer.pdfPeptic ulcer.pdf
Peptic ulcer.pdf
UVAS
 
Intestinal obstruction surgery adult health nursing.pptx
Intestinal obstruction surgery adult health nursing.pptxIntestinal obstruction surgery adult health nursing.pptx
Intestinal obstruction surgery adult health nursing.pptx
zobiapervaz
 
DIGESTIVE SYSTEM. PPT human anatomy and physiology
DIGESTIVE SYSTEM. PPT human anatomy and physiologyDIGESTIVE SYSTEM. PPT human anatomy and physiology
DIGESTIVE SYSTEM. PPT human anatomy and physiology
Trupthibv1
 
Stomach disorders
Stomach disorders Stomach disorders
Stomach disorders
Uma Binoy
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
specialclass
 
Gastitis,treatment, symptoms, 4042024.ppt
Gastitis,treatment, symptoms, 4042024.pptGastitis,treatment, symptoms, 4042024.ppt
Gastitis,treatment, symptoms, 4042024.ppt
ddjumanalieva97
 
Peptic Ulcer disease
Peptic Ulcer disease Peptic Ulcer disease
Peptic Ulcer disease
Sadasivarao Galaba
 
Stomach pathology lecture
Stomach pathology lectureStomach pathology lecture
Stomach pathology lecture
Drsapna Harsha
 
Peptic Ulcer Disease
Peptic Ulcer DiseasePeptic Ulcer Disease
Peptic Ulcer Disease
Dr Adnan Sami
 
4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptx4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptx
monthjanuary662
 
Complications of ulcer disease
Complications of ulcer diseaseComplications of ulcer disease
Complications of ulcer disease
Aman Baloch
 
Hegazypancreatitis
HegazypancreatitisHegazypancreatitis
Hegazypancreatitis
mostafa hegazy
 

Similar to 4584623.ppt (20)

Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
.pptx
.pptx.pptx
.pptx
 
Acute abdomen
Acute abdomenAcute abdomen
Acute abdomen
 
Git
GitGit
Git
 
Acute abdomen
Acute abdomenAcute abdomen
Acute abdomen
 
gastic and duodenal disorders
gastic and duodenal disordersgastic and duodenal disorders
gastic and duodenal disorders
 
Jejunal hemorrhagic syndrome
Jejunal hemorrhagic syndromeJejunal hemorrhagic syndrome
Jejunal hemorrhagic syndrome
 
PUD.pptx
PUD.pptxPUD.pptx
PUD.pptx
 
Peptic ulcer.pdf
Peptic ulcer.pdfPeptic ulcer.pdf
Peptic ulcer.pdf
 
Intestinal obstruction surgery adult health nursing.pptx
Intestinal obstruction surgery adult health nursing.pptxIntestinal obstruction surgery adult health nursing.pptx
Intestinal obstruction surgery adult health nursing.pptx
 
DIGESTIVE SYSTEM. PPT human anatomy and physiology
DIGESTIVE SYSTEM. PPT human anatomy and physiologyDIGESTIVE SYSTEM. PPT human anatomy and physiology
DIGESTIVE SYSTEM. PPT human anatomy and physiology
 
Stomach disorders
Stomach disorders Stomach disorders
Stomach disorders
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Gastitis,treatment, symptoms, 4042024.ppt
Gastitis,treatment, symptoms, 4042024.pptGastitis,treatment, symptoms, 4042024.ppt
Gastitis,treatment, symptoms, 4042024.ppt
 
Peptic Ulcer disease
Peptic Ulcer disease Peptic Ulcer disease
Peptic Ulcer disease
 
Stomach pathology lecture
Stomach pathology lectureStomach pathology lecture
Stomach pathology lecture
 
Peptic Ulcer Disease
Peptic Ulcer DiseasePeptic Ulcer Disease
Peptic Ulcer Disease
 
4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptx4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptx
 
Complications of ulcer disease
Complications of ulcer diseaseComplications of ulcer disease
Complications of ulcer disease
 
Hegazypancreatitis
HegazypancreatitisHegazypancreatitis
Hegazypancreatitis
 

More from NasserSalah6

M-ANASARCA, asites-bny7764y5wf16-12-14.ppt
M-ANASARCA, asites-bny7764y5wf16-12-14.pptM-ANASARCA, asites-bny7764y5wf16-12-14.ppt
M-ANASARCA, asites-bny7764y5wf16-12-14.ppt
NasserSalah6
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
NasserSalah6
 
b4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptx
b4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptxb4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptx
b4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptx
NasserSalah6
 
cyanosis.ppt
cyanosis.pptcyanosis.ppt
cyanosis.ppt
NasserSalah6
 
cvs.ppt
cvs.pptcvs.ppt
cvs.ppt
NasserSalah6
 
adrenal diese.pptx
adrenal diese.pptxadrenal diese.pptx
adrenal diese.pptx
NasserSalah6
 
cushingssyndrome-150922012501-lva1-app6891.pptx
cushingssyndrome-150922012501-lva1-app6891.pptxcushingssyndrome-150922012501-lva1-app6891.pptx
cushingssyndrome-150922012501-lva1-app6891.pptx
NasserSalah6
 
lymphoma-170322153654.pptx
lymphoma-170322153654.pptxlymphoma-170322153654.pptx
lymphoma-170322153654.pptx
NasserSalah6
 
hypopituitarism-210718093944.pptx
hypopituitarism-210718093944.pptxhypopituitarism-210718093944.pptx
hypopituitarism-210718093944.pptx
NasserSalah6
 
problem-basedlearning-140901120421-phpapp01.pptx
problem-basedlearning-140901120421-phpapp01.pptxproblem-basedlearning-140901120421-phpapp01.pptx
problem-basedlearning-140901120421-phpapp01.pptx
NasserSalah6
 
5-Approach to the patients with shock.ppt
5-Approach to the patients with shock.ppt5-Approach to the patients with shock.ppt
5-Approach to the patients with shock.ppt
NasserSalah6
 
leukemia1-230103123650-8c41bba7.pptx
leukemia1-230103123650-8c41bba7.pptxleukemia1-230103123650-8c41bba7.pptx
leukemia1-230103123650-8c41bba7.pptx
NasserSalah6
 
lymphoma-170322153654 (1).pptx
lymphoma-170322153654 (1).pptxlymphoma-170322153654 (1).pptx
lymphoma-170322153654 (1).pptx
NasserSalah6
 
diarrhoeacasepresentation-161202071537.pptx
diarrhoeacasepresentation-161202071537.pptxdiarrhoeacasepresentation-161202071537.pptx
diarrhoeacasepresentation-161202071537.pptx
NasserSalah6
 
seiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptx
seiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptxseiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptx
seiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptx
NasserSalah6
 
8600558.ppt
8600558.ppt8600558.ppt
8600558.ppt
NasserSalah6
 
07_basics_of_transfusion_therapy.ppt
07_basics_of_transfusion_therapy.ppt07_basics_of_transfusion_therapy.ppt
07_basics_of_transfusion_therapy.ppt
NasserSalah6
 
respiratorydisease-170426125838.pptx
respiratorydisease-170426125838.pptxrespiratorydisease-170426125838.pptx
respiratorydisease-170426125838.pptx
NasserSalah6
 
ACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.pptACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.ppt
NasserSalah6
 
5809079.ppt
5809079.ppt5809079.ppt
5809079.ppt
NasserSalah6
 

More from NasserSalah6 (20)

M-ANASARCA, asites-bny7764y5wf16-12-14.ppt
M-ANASARCA, asites-bny7764y5wf16-12-14.pptM-ANASARCA, asites-bny7764y5wf16-12-14.ppt
M-ANASARCA, asites-bny7764y5wf16-12-14.ppt
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 
b4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptx
b4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptxb4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptx
b4a061affc406d97404a9c1d5076ea7f_65219d5889f01.pptx
 
cyanosis.ppt
cyanosis.pptcyanosis.ppt
cyanosis.ppt
 
cvs.ppt
cvs.pptcvs.ppt
cvs.ppt
 
adrenal diese.pptx
adrenal diese.pptxadrenal diese.pptx
adrenal diese.pptx
 
cushingssyndrome-150922012501-lva1-app6891.pptx
cushingssyndrome-150922012501-lva1-app6891.pptxcushingssyndrome-150922012501-lva1-app6891.pptx
cushingssyndrome-150922012501-lva1-app6891.pptx
 
lymphoma-170322153654.pptx
lymphoma-170322153654.pptxlymphoma-170322153654.pptx
lymphoma-170322153654.pptx
 
hypopituitarism-210718093944.pptx
hypopituitarism-210718093944.pptxhypopituitarism-210718093944.pptx
hypopituitarism-210718093944.pptx
 
problem-basedlearning-140901120421-phpapp01.pptx
problem-basedlearning-140901120421-phpapp01.pptxproblem-basedlearning-140901120421-phpapp01.pptx
problem-basedlearning-140901120421-phpapp01.pptx
 
5-Approach to the patients with shock.ppt
5-Approach to the patients with shock.ppt5-Approach to the patients with shock.ppt
5-Approach to the patients with shock.ppt
 
leukemia1-230103123650-8c41bba7.pptx
leukemia1-230103123650-8c41bba7.pptxleukemia1-230103123650-8c41bba7.pptx
leukemia1-230103123650-8c41bba7.pptx
 
lymphoma-170322153654 (1).pptx
lymphoma-170322153654 (1).pptxlymphoma-170322153654 (1).pptx
lymphoma-170322153654 (1).pptx
 
diarrhoeacasepresentation-161202071537.pptx
diarrhoeacasepresentation-161202071537.pptxdiarrhoeacasepresentation-161202071537.pptx
diarrhoeacasepresentation-161202071537.pptx
 
seiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptx
seiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptxseiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptx
seiw_Inflammatory-Bowel-Diseases-PowerPoint-Presentation.pptx
 
8600558.ppt
8600558.ppt8600558.ppt
8600558.ppt
 
07_basics_of_transfusion_therapy.ppt
07_basics_of_transfusion_therapy.ppt07_basics_of_transfusion_therapy.ppt
07_basics_of_transfusion_therapy.ppt
 
respiratorydisease-170426125838.pptx
respiratorydisease-170426125838.pptxrespiratorydisease-170426125838.pptx
respiratorydisease-170426125838.pptx
 
ACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.pptACUTE VIRAL HEPATITIS.ppt
ACUTE VIRAL HEPATITIS.ppt
 
5809079.ppt
5809079.ppt5809079.ppt
5809079.ppt
 

Recently uploaded

Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 

Recently uploaded (20)

Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 

4584623.ppt

  • 2. Peptic Ulcer Disease  Condition characterized by  Erosion of GI mucosa resulting from digestive action of HCl and pepsin
  • 3. Peptic Ulcer Disease  Ulcer development  Lower esophagus  Stomach  Duodenum  10% of men, 4% of women
  • 4. Types  Acute  Superficial erosion  Minimal erosion  Chronic  Muscular wall erosion with formation of fibrous tissue  Present continuously for many months or intermittently
  • 5. Peptic Ulcer Disease Etiology and Pathophysiology  Develop only in presence of acid environment  Excess of gastric acid not necessary for ulcer development  Person with a gastric ulcer has normal to less than normal gastric acidity compared with person with a duodenal ulcer
  • 6. Peptic Ulcer Disease Etiology and Pathophysiology  Some intraluminal acid does seem to be essential for a gastric ulcer to occur  Pepsinogen is activated to pepsin in presence of HCl and a pH of 2 to 3  Secretion of HCl by parietal cells has a pH of 0.8  pH reaches 2 to 3 after mixing with stomach contents
  • 7. Peptic Ulcer Disease Etiology and Pathophysiology  At pH level 3.5 or more, stomach acid is neutralized  Pepsin has little or no proteolytic activity  Surface mucosa of stomach is renewed about every 3 days  Mucosa can continually repair itself except in extreme instances
  • 8. Peptic Ulcer Disease Etiology and Pathophysiology  Mucosal barrier prevents back diffusion of acid from gastric lumen through mucosal layers to underlying tissue  Mucosal barrier can be impaired and back diffusion can occur
  • 10. Peptic Ulcer Disease Etiology and Pathophysiology  HCl freely enters mucosa when barrier is broken  Injury to tissue occurs  Result: cellular destruction and inflammation
  • 11. Peptic Ulcer Disease Etiology and Pathophysiology  Histamine is released  Vasodilation, ↑ capillary permeability  Further secretion of acid and pepsin
  • 12. Peptic Ulcer Disease Etiology and Pathophysiology  Ulcerogenic drugs inhibit synthesis of prostaglandins and cause abnormal permeability  Corticosteroids ↓ rate of mucosal cell renewal thereby ↓ protective effects
  • 13. Peptic Ulcer Disease Etiology and Pathophysiology  When mucosal barrier is disrupted, there is a compensatory ↑ in blood flow  Prostaglandin-like substances, histamines act as vasodilators  Hydrogen ions are rapidly removed  Buffers are delivered  Nutrients arrive  ↑ Mucosal cell replication
  • 14. Disruption of Gastric Mucosal Barrier Fig. 40-14
  • 15. Peptic Ulcer Disease Etiology and Pathophysiology  When blood flow is not sufficient, tissue injury results
  • 16. Peptic Ulcer Disease Etiology and Pathophysiology  Two mechanisms that protect  Mucus forms a layer that entraps or slows diffusion of hydrogen ions across mucosal barrier  Bicarbonate is secreted  Neutralizes HCl acid in lumen of GI tract
  • 17. Peptic Ulcer Disease Etiology and Pathophysiology  ↑ Vagal nerve stimulation results in hypersecretion of HCl acid  ↑ HCl acid can alter mucosal barrier  Duodenal ulcers are associated with ↑ acid
  • 18. Gastric Ulcers  Commonly found on lesser curvature in close proximity to antral junction  Less common than duodenal ulcers  Prevalent in women, older adults, persons from lower socioeconomic class
  • 19. Gastric Ulcers  Characterized by  A normal to low secretion of gastric acid  Back diffusion of acid is greater (chronic)
  • 20. Gastric Ulcers  Critical pathologic process is amount of acid able to penetrate mucosal barrier  H. pylori is present in 50% to 70%
  • 21. Gastric Ulcers  H. pylori is thought to be more destructive when noxious agents are used, or patient smokes
  • 22. Gastric Ulcers  Drugs can cause acute gastric ulcers  Aspirin, corticosteroids, NSAIDs, reserpine  Or known causative factors  Chronic alcohol abuse, chronic gastritis
  • 23. Duodenal Ulcers  Occur at any age and in anyone  ↑ Between ages of 35 to 45 years  Account for ~80% of all peptic ulcers
  • 24. Duodenal Ulcers  Associated with ↑ HCl acid secretion  H. pylori is found in 90-95% of patients  Direct relationship has not been found
  • 25. Duodenal Ulcers  Diseases with ↑ risk of duodenal ulcers  COPD, cirrhosis of liver, chronic pancreatitis, hyperparathyroidism, chronic renal failure  Treatments used for these conditions may promote ulcer development
  • 26. Psychological Stress Ulcers  Acute ulcers that develop following a major physiologic insult such as trauma or surgery  A form of erosive gastritis
  • 27. Psychological Stress Ulcers  Gastric mucosa of body of stomach undergoes a period of transient ischemia in association with  Hypotension  Severe injury  Extensive burns  Complicated surgery
  • 28. Psychological Stress Ulcers  Ischemia due to ↓ capillary blood flow or shunting of blood away from GI tract so that blood flow bypasses gastric mucosa  Imbalance between destructive properties of HCl acid and pepsin, and protective factors of stomach’s mucosal barrier
  • 29. Peptic Ulcer Disease Clinical Manifestations  Common to have no pain or other symptoms  Gastric and duodenal mucosa not rich in sensory pain fibers  Duodenal ulcer pain  Burning, cramplike  Gastric ulcer pain  Burning, gaseous
  • 30. Peptic Ulcer Disease Complications  3 major complications  Hemorrhage  Perforation  Gastric outlet obstruction  Initially treated conservatively  May require surgery at any time during course of therapy
  • 31. Peptic Ulcer Disease Hemorrhage  Most common complication of peptic ulcer disease  Develops from erosion of  Granulation tissue found at base of ulcer during healing  Ulcer through a major blood vessel
  • 32. Peptic Ulcer Disease Perforation  Most lethal complication of peptic ulcer  Commonly seen in large penetrating duodenal ulcers that have not healed and are located on posterior mucosal wall
  • 33. Peptic Ulcer Disease Perforation  Perforated gastric ulcers often located on lesser curvature of stomach
  • 35. Peptic Ulcer Disease Perforation  Occurs when ulcer penetrates serosal surface  Spillage of their gastric or duodenal contents into peritoneal cavity  Size of perforation directly proportional to length of time patient has had ulcer  Sudden, dramatic onset
  • 36. Peptic Ulcer Disease Gastric Outlet Obstruction  Ulcers located in antrum and prepyloric and pyloric areas of stomach  Duodenum can predispose to gastric outlet obstruction  ↑ contractile force needed to empty stomach results in hypertrophy of stomach wall
  • 37. Peptic Ulcer Disease Gastric Outlet Obstruction  After longstanding obstruction stomach enters decompensated phase  Results in dilation and atony
  • 38. Peptic Ulcer Disease Gastric Outlet Obstruction  Obstruction is not totally due to fibrous scar tissue  Active ulcer formation is associated with edema, inflammation, pylorospasm  All contribute to narrowing of pylorus
  • 39. Peptic Ulcer Disease Gastric Outlet Obstruction  Usually has a history of ulcer pain  Short duration or absence of pain indicative of a malignant obstruction
  • 40. Peptic Ulcer Disease Gastric Outlet Obstruction  Vomiting is common  Constipation is a common complaint  Dehydration, lack of roughage in diet  May show swelling in upper abdomen
  • 41. Peptic Ulcer Disease Diagnostic Studies  Endoscopy procedure most often used  Determines degree of ulcer healing after treatment  Tissue specimens can be obtained to identify H. pylori and to rule out gastric cancer
  • 42. Peptic Ulcer Disease Diagnostic Studies  Tests for H. pylori  Noninvasive tests  Serum or whole blood antibody tests  Immunoglobin G (IgG)  Urea breath test  Invasive tests  Biopsy of stomach  Rapid urease test
  • 43. Peptic Ulcer Disease Diagnostic Studies  Barium contrast studies  Widely used  X-ray studies  Ineffective in differentiating a peptic ulcer from a malignant tumor
  • 44. Peptic Ulcer Disease Diagnostic Studies  Gastric analysis  Identifying a possible gastrinoma  Determining degree of gastric hyperacidity  Evaluating results of therapy
  • 45. Peptic Ulcer Disease Diagnostic Studies  Laboratory analysis  CBC  Urinalysis  Liver enzyme studies  Serum amylase determination  Stool examination